Delivery Order SPE2DB22D3301-SPE2DB25FY6MK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,543.90 to AmerisourceBergen Drug Corp for Pylera Capsule UU 120s, a pharmaceutical product used in bacterial infection treatment. The order was competitively awarded without set-aside designation and is scheduled for completion by September 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performing location for this firm fixed-price delivery order. This delivery order represents a single...
- The Defense Logistics Agency awarded a delivery order valued at $1,172.71 to AmerisourceBergen Drug Corp for Pylera Capsule UU 120s, a pharmaceutical product used to treat Helicobacter pylori infections. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of April 22, 2025. This award is a child delivery order under AmerisourceBergen Drug...
- The Defense Logistics Agency's Medical Supply Chain awarded a competitive delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for Pylera Capsule UU 120s, a combination antibiotic medication used to treat Helicobacter pylori infections. The contract is valued at $2,266.10 under a firm fixed-price arrangement, with an ultimate completion date of April 25, 2025. This award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $117,683.14 firm fixed-price contract is for the supply of PYLERA CAPSULE UU 120S, with a completion date of September 21, 2022. This award is associated with a larger Indefinite Delivery Contract (IDC) worth $999,999,999, which Amerisourcebergen holds with the DLA Troop Support Medical for providing a comprehensive range...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $26,954.56 for ORSERDU 345 mg tablets (30-count) on October 20, 2025, with completion scheduled for November 10, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order valued at $2,393.67 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This is a firm fixed price delivery order with an ultimate completion date of October 21, 2025, issued under a non-set-aside competitive procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,202.50 to AmerisourceBergen Drug Corp on November 4, 2025, under the Pharmaceutical Prime Vendor Global Program. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. This delivery order represents a non-competitive award under an existing firm fixed-price contract vehicle, consistent...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, with a ceiling value of $6,044.60 and an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a task order under AmerisourceBergen's broader relationship with the federal government's military healthcare procurement system. The prime contractor is headquartered in...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $4,575.90 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,705.93 to AmerisourceBergen Drug Corp on July 14, 2025, with an ultimate completion date of July 15, 2025. The delivery order (4568785087) is for pharmaceutical products specified as "DT 1C 2.25X4 700/RL 6RL/BX DHAPCL," to be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This is a firm fixed-price, non-set-aside contract awarded through competitive procurement, consistent with...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY6MKDelivery Order
The Defense Logistics Agency awarded a $2,731.83 delivery order to AmerisourceBergen Drug Corp for Pylera Capsule UU 120s, with an ultimate completion date of June 20, 2025. This is a firm fixed price, non-set-aside contract performed at the awardee's Corporate Office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's existing contract vehicle with DLA. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a leading pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. The company's comprehensive pharmaceutical portfolio under this prime indefinite delivery vehicle enables the supply of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs globally, including services to the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 6/18/25 |